Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method for the intranasal administration of 3-[2-(dimethylamino)-ethyl]-H-methyl-1H-indole-5-methanesulphonamide

US Patent 5393773 · Granted Feb 28, 1995

Assignee

Inventors

View full patent text on Google Patents →